Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3126
BW LPG
BWLP
$3.89B
| $1.46M | ﹤0.01% |
111,828
-77,403
| -41% | -$989K |
2024 Q2
6 quarters
|
|
3127
Mercer International
MERC
$17.2M
| $1.46M | ﹤0.01% |
739,335
+726,120
| +5,495% | +$1.53M |
2020 Q2
22 quarters
|
|
|
AMTM
3128
Amentum Holdings
AMTM
$4.44B
| $1.46M | ﹤0.01% |
50,375
-3,287
| -6% | -$84K |
2024 Q3
5 quarters
|
|
|
CAI
3129
Caris Life Sciences
CAI
$8B
| $1.46M | ﹤0.01% |
54,117
+50,940
| +1,603% | +$1.43M |
2025 Q2
2 quarters
|
|
3130
Empire State Realty Trust
ESRT
$722M
| $1.46M | ﹤0.01% |
223,744
+8,316
| +4% | +$59.4K |
2013 Q4
48 quarters
|
|
3131
FuboTV Inc
FUBO
$262M
| $1.46M | ﹤0.01% |
48,236
-2,487
| -5% | -$99.3K |
2022 Q1
15 quarters
|
|
3132
HBT Financial
HBT
$1.32B
| $1.46M | ﹤0.01% |
56,317
+1,732
| +3% | +$42.8K |
2022 Q1
15 quarters
|
|
3133
Annexon
ANNX
$794M
| $1.46M | ﹤0.01% |
289,963
+142,033
| +96% | +$543K |
2022 Q1
15 quarters
|
|
3134
Concentrix
CNXC
$1.52B
| $1.45M | ﹤0.01% |
34,977
-44,009
| -56% | -$1.79M |
2022 Q1
15 quarters
|
|
3135
Navigator Holdings
NVGS
$1.47B
| $1.45M | ﹤0.01% |
83,875
-9,696
| -10% | -$162K |
2019 Q2
26 quarters
|
|
|
PRSU
3136
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $1.45M | ﹤0.01% |
43,123
+13,129
| +44% | +$458K |
2016 Q3
37 quarters
|
|
|
BKV
3137
BKV Corp
BKV
$2.36B
| $1.45M | ﹤0.01% |
53,430
+29,672
| +125% | +$745K |
2024 Q3
5 quarters
|
|
|
TRST
3138
Trustco Bank Corp NY
TRST
$948M
| $1.45M | ﹤0.01% |
35,073
+7,721
| +28% | +$308K |
2022 Q1
15 quarters
|
|
3139
Altimmune
ALT
$531M
| $1.45M | ﹤0.01% |
400,595
+60,312
| +18% | +$263K |
2020 Q2
22 quarters
|
|
|
AIV
3140
Aimco
AIV
$280M
| $1.45M | ﹤0.01% |
243,343
+10,385
| +4% | +$62.2K |
2022 Q1
15 quarters
|
|
3141
Teekay
TK
$1.3B
| $1.44M | ﹤0.01% |
159,950
+86,506
| +118% | +$796K |
2013 Q4
48 quarters
|
|
3142
PDF Solutions
PDFS
$2.34B
| $1.44M | ﹤0.01% |
50,556
+925
| +2% | +$25.6K |
2016 Q2
38 quarters
|
|
|
DEA
3143
Easterly Government Properties
DEA
$1.11B
| $1.44M | ﹤0.01% |
68,008
+8,102
| +14% | +$176K |
2016 Q2
38 quarters
|
|
|
QXO
3144
QXO Inc
QXO
$12.5B
| $1.44M | ﹤0.01% |
74,669
-503,510
| -87% | -$9.65M |
2024 Q4
4 quarters
|
|
3145
CALL
American Tower
AMT
$75.6B
| $1.44M | ﹤0.01% |
8,200
+8,100
| +8,100% | +$1.47M |
2025 Q2
2 quarters
|
|
3146
Middlesex Water
MSEX
$1.01B
| $1.44M | ﹤0.01% |
28,545
+3,341
| +13% | +$180K |
2016 Q1
39 quarters
|
|
3147
PUT
FTAI Aviation
FTAI
$17.2B
| $1.44M | ﹤0.01% |
+7,300
| New | +$1.24M |
2025 Q4
0 quarters
|
|
3148
CytomX Therapeutics
CTMX
$558M
| $1.43M | ﹤0.01% |
336,525
+335,035
| +22,486% | +$1.27M |
2025 Q1
3 quarters
|
|
|
BOW
3149
Bowhead Specialty Holdings
BOW
$1.11B
| $1.43M | ﹤0.01% |
50,182
-34,310
| -41% | -$910K |
2024 Q3
5 quarters
|
|
3150
CALL
Mastercard
MA
$484B
| $1.43M | ﹤0.01% |
2,500
| – | – |
2025 Q2
2 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.